Clifford E. Berkman
Professor
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (6)
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
New targeted chemotherapeutics are urgently needed to minimize off-target toxicity and reduce the high-mortality rate associated with metastatic prostate cancer. Herein, we report on the modular synthesis, pharmacokinetics, and efficacy of two small-molecule–drug conjugates (SMDC) targeted to prostate-specific membrane antigen (PSMA) incorporating either: (i) a cathepsin-B–cleavable valine–citrulline (Val–Cit), or (ii) an acid-cleavable phosphoramidate linker. Crucial components used in the design of the conjugates include: (i) CTT1298, a nanomolar affinity ligand that binds irreversibly to PSMA and has proven in past studies to rapidly internalize and shuttle payloads into PSMA-expressing prostate cancer cells, (ii) MMAE, a known potent cytotoxic payload, and (iii) an albumin-binder, proven to improve residence time of drug conjugates. At dose of 0.8 mg/kg (∼250 nmol/kg), the two SMDCs showed significant efficacy in a PSMA(+) PC3-PIP mouse model of human prostate cancer compared with controls, without inducing systemic toxicity. Though localization of the SMDCs was observed in tissues apart from the tumor, release of MMAE was observed predominantly in tumor tissue, at levels that were 2–3 orders of magnitude higher than non-target tissues. Furthermore, SMDC2, which incorporated a novel pH-responsive phosporamidate linker, demonstrated significantly improved efficacy over SMDC1 that has a Val–Cit linker, with a 100% survival over 90 days and 4 out of 8 mice showing complete tumor growth inhibition after 6 weekly doses of 0.8 mg/kg (244 nmol/kg). Our findings demonstrate the potential of irreversible PSMA inhibitors combined with pH-responsive linkers as a way to specifically deliver chemotherapeutic drugs to prostate cancer tumors with minimal toxicity.
Year:
2022
Collaborators (27)
Steven G. Boxer
Professor
Stanford University
Yu-Shan Lin
Professor of Chemistry and Dean of Academic Affairs for Arts and Sciences
Tufts University
Ronald Castellano
Professor
University of Florida
William T. Pennington
Department Chair
Clemson University
Ricardo Metz
Professor
University of Massachusetts Amherst
D. Howard Fairbrother
-
Linda Columbus
Professor
University of Virginia
Anjali Sharma
Assistant Professor
Washington State University
Tristan H. Lambert
Cornell University
Wei Kong
Oregon State University
Gregory J. Szulczewski
-
Vicki H. Wysocki
Professor, School chair
Georgia Institute of Technology
Laura J. Kaufman
Columbia University
Gregory S. Ferguson
Professor and Chair
Lehigh University
Frieder Jäkle
Distinguished Professor
Rutgers University
Michael Burkart
Professor
University of California, San Diego
Jin Zhang
Distinguished Professor
-
Karen Allen
Professor
Boston University
Melody Fulton
Staff Scientist
Washington State University
Victoria J. DeRose
University of Oregon
P. B. Armentrout
Distinguished Professor
University of Utah
Matthew P. Shores
Colorado State University
Lai-Sheng Wang
Brown University
Christy Haynes
University of Minnesota
Catherine J. Murphy
Larry R. Faulkner Endowed Chair in Chemistry
University of Illinois at Urbana-Champaign
Kenneth Knappenberger
Professor
The Pennsylvania State University - University Park Campus
Alexander M. Spokoyny
University of California
Make your next move.
Prepare your application
Review drafts before you send them.